| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Regulatory Compliance > Important Document Security Regulations |
|
Answers - Important Document Security Regulations
At our current technological level it is easy to forget some of the security basics. Identity theft, bank fraud and o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ther so called modern crimes have been around for some time, they just have new ways of being committed. That said, i ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in 's a good idea for all of us to review some of the laws and regulations that are currently in place. Health Insurance lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. Portability & Accountability Act (HIPAA) HIPAA was enacted in 1996 and the mandatory compliance date is April 1 here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe , 2003. All hospitals, doctors, pharmacies, health plans, medical billing companies and any other business entity invo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro lved in the health care industry must comply. The rules apply to all protected health information. The Standard for Pr ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc vacy of Identifiable Health Information requires that covered entities put in place administrative, technical and phys easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ical safeguards to protect the privacy of protected health information. One example given of a safeguard for the prope nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically disposal of paper documents containing protected health information is that the documents be shredded prior to dispos and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ al. Find out more >> Gramm-Leach-Bliley Act (1999) Financial Services Modernization Act This Federal legislatio ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi went into effect in 2000, the privacy provisions in the law require that financial institutions and insurance compani ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s give consumers prior notice of an intention to share personal information and a chance to opt out of the sharing of dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod such information. The law states that these institutions and companies need to "respect the privacy of its customers a cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin d to protect the security and confidentiality of those customers' non-public information." The language suggest that p tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen aper documents containing such personal information should also be protected and safely destroyed. Find out more >> F t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel deral Privacy Act of 1974 This law was established in 1974 to insure that government agencies protect the privac ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust y of individuals and businesses with regard to information held by them and to hold these agencies liable for any info y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mation released without proper authorization. Supreme Court Case California v Greenwood, The US Supreme Court r . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de uled in 1988 that any item placed in the trash is considered public information. These are just the major ones. Do y elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip u, your family and your business a favor and look into some professional document security and paper shredding options tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Resell Rights: Are They the Fastest Way to Online Profits? Does Your Ezine Publisher Try To Rape Your Pocket? A Guide to Choosing Income Rating Tax Software
|